Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

Condition:   Ulcerative Colitis Interventions:   Drug: Tilpisertib Fosmecarbil;   Drug: Placebo Sponsor:   Gilead Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials